(Q33909908)

30 July 2017

1 reference

title

Vaccines for preventing influenza in people with cystic fibrosis. (English)

1 reference

30 July 2017

0 references

A Tan

1

1 reference

30 July 2017

P Bhalla

series ordinal

2

1 reference

30 July 2017

R Smyth

series ordinal

3

1 reference

30 July 2017

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

30 July 2017

published in

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

CD001753

1 reference

Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Influenza vaccination in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Effects of upper respiratory tract infections in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Acute severe deterioration in cystic fibrosis associated with influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Impact of influenza on morbidity in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Antibody response to whole-virus and split-virus influenza vaccines in successful ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Comparison of live and inactivated influenza vaccine in high risk children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

Liposomal influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753

10.1002/14651858.CD001753

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference